This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shen, J. Articles by Santella, R. M. Search for Related Content PubMed PubMed Citation Articles by Shen, J. Articles by Santella, R. M.

Short Telomere Length and Breast Cancer Risk: A Study in Sister Sets

Departments of ¹ Environmental Health Sciences and ² Epidemiology, Mailman School of Public Health, Columbia University, New York, New York

Requests for reprints: Jing Shen, Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, 630 West 168th Street, P&S 19-418, New York, NY 10032. Phone: 212-305-8158; Fax: 212-305-5328; E-mail: js2182{at}columbia.edu.

Telomeres consist of a tandem repeats of the sequence TTAGGG at the ends of chromosomes and play a key role in the maintenance of chromosomal stability. Previous studies indicated that short telomeres are associated with increased risk for human bladder, head and neck, lung, and renal cell cancer. We investigated the association between white blood cell telomere length and breast cancer risk among 268 family sets (287 breast cancer cases and 350 sister controls). Telomere length was assessed by quantitative PCR. The mean telomere length was shorter in cases (mean, 0.70; range, 0.03–1.95) than in unaffected control sisters (mean, 0.74; range, 0.03–2.29), but no significant difference was observed (P = 0.11). When subjects were categorized according to the median telomere length in controls (0.70), affected sisters had shorter telomeres compared with unaffected sisters after adjusting for age at blood donation and smoking status [odds ratio (OR), 1.3; 95% confidence interval (95% CI), 0.9–1.8], but the association was not statistically significant. The association by quartile of telomere length (Q4 shortest versus Q1 longest) also supported an increase in risk from shorter telomere length, although the association was not statistically significant (OR, 1.6; 95% CI, 0.9–2.7). This association was more pronounced among premenopausal women (OR, 2.1; 95% CI, 0.8–5.5) than postmenopausal women (OR, 1.3; 95% CI, 0.5–3.6 for Q4 versus Q1). If these associations are replicated in larger studies, they provide modest epidemiologic evidence that shortened telomere length may be associated with breast cancer risk. [Cancer Res 2007;67(11):5538–44]

This article has been cited by other articles:

				M. Capezzone, S. Cantara, S. Marchisotta, S. Filetti, M. M. De Santi, B. Rossi, G. Ronga, C. Durante, and F. Pacini Short Telomeres, Telomerase Reverse Transcriptase Gene Amplification, and Increased Telomerase Activity in the Blood of Familial Papillary Thyroid Cancer Patients J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3950 - 3957. [Abstract] [Full Text] [PDF]

				U. Svenson, K. Nordfjall, B. Stegmayr, J. Manjer, P. Nilsson, B. Tavelin, R. Henriksson, P. Lenner, and G. Roos Breast Cancer Survival Is Associated with Telomere Length in Peripheral Blood Cells Cancer Res., May 15, 2008; 68(10): 3618 - 3623. [Abstract] [Full Text] [PDF]